JPS322220B1 - - Google Patents

Info

Publication number
JPS322220B1
JPS322220B1 JP2601554A JP2601554A JPS322220B1 JP S322220 B1 JPS322220 B1 JP S322220B1 JP 2601554 A JP2601554 A JP 2601554A JP 2601554 A JP2601554 A JP 2601554A JP S322220 B1 JPS322220 B1 JP S322220B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2601554A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP2601554A priority Critical patent/JPS322220B1/ja
Publication of JPS322220B1 publication Critical patent/JPS322220B1/ja
Pending legal-status Critical Current

Links

JP2601554A 1954-11-30 1954-11-30 Pending JPS322220B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2601554A JPS322220B1 (en) 1954-11-30 1954-11-30

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2601554A JPS322220B1 (en) 1954-11-30 1954-11-30

Publications (1)

Publication Number Publication Date
JPS322220B1 true JPS322220B1 (en) 1957-04-11

Family

ID=45422381

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2601554A Pending JPS322220B1 (en) 1954-11-30 1954-11-30

Country Status (1)

Country Link
JP (1) JPS322220B1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070893A3 (en) * 2004-01-09 2007-01-18 Corcept Therapeutics Inc Azadecalin glucocorticoid receptor modulators
US10047082B2 (en) 2013-11-25 2018-08-14 Corcept Therapeutics, Inc. Octahydro fused azadecalin glucocorticoid receptor modulators
US11058670B2 (en) 2019-02-22 2021-07-13 Corcept Therapeutics Incorporated Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
US11234971B2 (en) 2018-12-19 2022-02-01 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
US11389432B2 (en) 2018-12-19 2022-07-19 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
US11903945B2 (en) 2019-12-11 2024-02-20 Corcept Therapeutics Incorporated Methods of treating antipsychotic-induced weight gain with miricorilant

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070893A3 (en) * 2004-01-09 2007-01-18 Corcept Therapeutics Inc Azadecalin glucocorticoid receptor modulators
JP2007517894A (en) * 2004-01-09 2007-07-05 コーセプト セラピューティクス， インコーポレイテッド Azadecalin glucocorticoid receptor modulator
US7678813B2 (en) 2004-01-09 2010-03-16 Corcept Therapeutics, Inc. Azadecalin Glucocorticoid receptor modulators
JP4851345B2 (en) * 2004-01-09 2012-01-11 コーセプト セラピューティクス， インコーポレイテッド Azadecalin glucocorticoid receptor modulator
US8324203B2 (en) 2004-01-09 2012-12-04 Corcept Therapeutics, Inc. Azadecalin glucocorticoid receptor modulators
US11560379B2 (en) 2013-11-25 2023-01-24 Corcept Therapeutics, Inc. Octahydro fused azadecalin glucocorticoid receptor modulators
US10323034B2 (en) 2013-11-25 2019-06-18 Corcept Therapeutics, Inc. Octahydro fused azadecalin glucocorticoid receptor modulators
US10787449B2 (en) 2013-11-25 2020-09-29 Corcept Therapeutics, Inc. Octahydro fused azadecalin glucocorticoid receptor modulators
US11370789B2 (en) 2013-11-25 2022-06-28 Corcept Therapeutics, Inc. Octahydro fused azadecalin glucocorticoid receptor modulators
US10047082B2 (en) 2013-11-25 2018-08-14 Corcept Therapeutics, Inc. Octahydro fused azadecalin glucocorticoid receptor modulators
US11234971B2 (en) 2018-12-19 2022-02-01 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
US11389432B2 (en) 2018-12-19 2022-07-19 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
US11058670B2 (en) 2019-02-22 2021-07-13 Corcept Therapeutics Incorporated Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
US11590113B2 (en) 2019-02-22 2023-02-28 Corcept Therapeutics Incorporated Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
US11684612B2 (en) 2019-02-22 2023-06-27 Corcept Therapeutics Incorporated Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator
US11903945B2 (en) 2019-12-11 2024-02-20 Corcept Therapeutics Incorporated Methods of treating antipsychotic-induced weight gain with miricorilant

Similar Documents

Publication Publication Date Title
JPS322220B1 (en)
AT195977B (en)
AT195459B (en)
FR1078876A (en)
FR1094705A (en)
FR1094623A (en)
AT196304B (en)
AT197898B (en)
AT195345B (en)
FR1053800A (en)
AT195836B (en)
AT196486B (en)
AT198617B (en)
AT196970B (en)
AT195221B (en)
AT195335B (en)
AT195552B (en)
AT195750B (en)
AT195822B (en)
AT195943B (en)
AT196650B (en)
AT196701B (en)
AT214341B (en)
AT199414B (en)
AT196784B (en)